The Korean Journal of Physiology and Pharmacology

  • 제17권6호
  • /
  • Pages.517-523
  • /
  • 2013
  • /
  • 1226-4512(pISSN)
  • /
  • 2093-3827(eISSN)
대한약리학회 (The Korean Society of Pharmacology)
권호 표지
DOI QR코드

DOI QR Code

Cytotoxicity and Structure-activity Relationships of Naphthyridine Derivatives in Human Cervical Cancer, Leukemia, and Prostate Cancer

  • 투고 : 2013.10.14
  • 심사 : 2013.11.15
  • 발행 : 2013.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Naphthyridine compounds are important, because they exhibit various biological activities including anticancer, antimicrobial, and anti-inflammatory activity. Some naphthyridines have antimitotic effects or demonstrate anticancer activity by inhibiting topoisomerase II. These compounds have been investigated as potential anticancer agents, and several compounds are now part of clinical trials. A series of naphthyridine derivatives were evaluated for their in vitro cytotoxic activities against human cervical cancer (HeLa), leukemia (HL-60), and prostate cancer (PC-3) cell lines using an MTT assay. Some compounds (14, 15, and 16) were more potent than colchicine against all three human cancer cell lines and compound (16) demonstrated potency with $IC_{50}$ values of 0.7, 0.1, and $5.1{\mu}M$, respectively. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were used for quantitative structure-activity relationship (QSAR) molecular modeling of these compounds. We obtained accurate and predictive three-dimensional QSAR (3D-QSAR) models as indicated by the high PLS parameters of the HeLa ($q^2$, 0.857; $r^2$, 0.984; $r^2\;_{pred}$, 0.966), HL-60 ($q^2$, 0.777; $q^2$, 0.937; $r^2\;_{pred}$, 0.913), and PC-3 ($q^2$, 0.702; $q^2$, 0.983; $r^2\;_{pred}$, 0.974) cell lines. The 3D-QSAR contour maps suggested that the C-1 NH and C-4 carbonyl group of the naphthyridine ring and the C-2 naphthyl ring were important for cytotoxicity in all three human cancer cell lines.

키워드

참고문헌

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96. https://doi.org/10.3322/CA.2007.0010
  2. Hu WP, Yu HS, Chen YR, Tsai YM, Chen YK, Liao CC, Chang LS, Wang JJ. Synthesis and biological evaluation of thiobenzanilides as anticancer agents. Bioorg Med Chem. 2008;16: 5295-5302. https://doi.org/10.1016/j.bmc.2008.03.003
  3. Kemnitzer W, Jiang S, Wang Y, Kasibhatla S, Crogan-Grundy C, Bubenik M, Labrecque D, Denis R, Lamothe S, Attardo G, Gourdeau H, Tseng B, Drewe J, Cai SX. Discovery of 4-aryl- 4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Part 5: modifications of the 2- and 3-positions. Bioorg Med Chem Lett. 2008;18:603-607. https://doi.org/10.1016/j.bmcl.2007.11.078
  4. Wordenmam L, Mitchison TJ. Dynamics of microtubule assembly in vivo. Modern Cell Biology. 1994;13:287-301.
  5. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253-265. https://doi.org/10.1038/nrc1317
  6. Xia Y, Yang ZY, Xia P, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Hackl T, Lee KH. Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4- tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents. J Med Chem. 1998;41:1155-1162. https://doi.org/10.1021/jm9707479
  7. Rowinsky EK, Donehower RC. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther. 1991;52:35-84. https://doi.org/10.1016/0163-7258(91)90086-2
  8. Verweij J, Clavel M, Chevalier B. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind. Ann Oncol. 1994;5: 495-505. https://doi.org/10.1093/oxfordjournals.annonc.a058903
  9. Shi Q, Chen K, Li L, Chang JJ, Autry C, Kozuka M, Konoshima T, Estes JR, Lin CM, Hamel E. Antitumor agents, 154. Cytotoxic and antimitotic flavonols from Polanisia dodecandra. J Nat Prod. 1995;58:475-482. https://doi.org/10.1021/np50118a001
  10. Manthey JA, Grohmann K, Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem. 2001;8:135-153. https://doi.org/10.2174/0929867013373723
  11. Hodek P, Trefil P, Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact. 2002;139:1-21. https://doi.org/10.1016/S0009-2797(01)00285-X
  12. Manthey JA, Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem. 2002;50:5837-5843. https://doi.org/10.1021/jf020121d
  13. Chan HY, Wang H, Leung LK. The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a]anthracene. Br J Nutr. 2003; 90:87-92. https://doi.org/10.1079/BJN2003868
  14. Lee D, Bhat KP, Fong HH, Farnsworth NR, Pezzuto JM, Kinghorn AD. Aromatase inhibitors from Broussonetia papyrifera. J Nat Prod. 2001;64:1286-1293. https://doi.org/10.1021/np010288l
  15. Pouget C, Fagnere C, Basly JP, Besson AE, Champavier Y, Habrioux G, Chulia AJ. Synthesis and aromatase inhibitory activity of flavanones. Pharm Res. 2002;19:286-291. https://doi.org/10.1023/A:1014490817731
  16. Lai YY, Huang LJ, Lee KH, Xiao Z, Bastow KF, Yamori T, Kuo SC. Synthesis and biological relationships of 3',6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents. Bioorg Med Chem. 2005;13:265-275. https://doi.org/10.1016/j.bmc.2004.09.041
  17. Li L, Wang HK, Kuo SC, Wu TS, Lednicer D, Lin CM, Hamel E, Lee KH. Antitumor agents. 150. 2',3',4',5',5,6,7-substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem. 1994;37:1126-1135. https://doi.org/10.1021/jm00034a010
  18. Zhang SX, Bastow KF, Tachibana Y, Kuo SC, Hamel E, Mauger A, Narayanan VL, Lee KH. Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem. 1999;42: 4081-4087. https://doi.org/10.1021/jm990208z
  19. Chen K, Kuo SC, Hsieh MC, Mauger A, Lin CM, Hamel E, Lee KH. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2- phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J Med Chem. 1997;40: 2266-2275. https://doi.org/10.1021/jm960858s
  20. Litvinov VP. Chemistry and biological activities of 1,8-naphthyridines. Russ Chem Rev. 2004;73:637-670. https://doi.org/10.1070/RC2004v073n07ABEH000856
  21. Kren V, Rezanka T. Sweet antibiotics - the role of glycosidic residues in antibiotic and antitumor activity and their randomization. FEMS Microbiol Rev. 2008;32:858-889. https://doi.org/10.1111/j.1574-6976.2008.00124.x
  22. Tsuzuki Y, Tomita K, Shibamori K, Sato Y, Kashimoto S, Chiba K. Synthesis and structure-activity relationships of novel 7- substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3- carboxylic acids as antitumor agents. Part 2. J Med Chem. 2004;47:2097-2109. https://doi.org/10.1021/jm0304966
  23. Tomita K, Tsuzuki Y, Shibamori K, Tashima M, Kajikawa F, Sato Y, Kashimoto S, Chiba K, Hino K. Synthesis and structure- activity relationships of novel 7-substituted 1,4-dihydro-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 1. J Med Chem. 2002;45:5564-5575. https://doi.org/10.1021/jm010057b
  24. Srivastava SK, Jha A, Agarwal SK, Mukherjee R, Burman AC. Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. Anticancer Agents Med Chem. 2007;7:685-709. https://doi.org/10.2174/187152007784111313
  25. Tsuzuki Y, Tomita K, Sato Y, Kashimoto S, Chiba K. Synthesis and structure-activity relationships of 3-substituted 1,4- dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents. Bioorg Med Chem Lett. 2004;14:3189-3193. https://doi.org/10.1016/j.bmcl.2004.04.011
  26. Abbas JA, Stuart RK. Vosaroxin: a novel antineoplastic quinolone. Expert Opin Investig Drugs. 2012;21:1223-1233. https://doi.org/10.1517/13543784.2012.699038
  27. Deady LW, Rogers ML, Zhuang L, Baguley BC, Denny WA. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones. Bioorg Med Chem. 2005; 13:1341-1355. https://doi.org/10.1016/j.bmc.2004.11.007
  28. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res. 1987;47:5875-5879.
  29. Manthey JA, Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem. 2002;50:5837-5843. https://doi.org/10.1021/jf020121d
  30. Hwang YJ, Park SM, Yim CB, Im C. Cytotoxic activity and quantitative structure activity relationships of arylpropyl sulfonamides. Korean J Physiol Pharmacol. 2013;17:237-243. https://doi.org/10.4196/kjpp.2013.17.3.237
  31. Lim JC, Park SY, Nam Y, Nguyen TT, Sohn UD. The protective effect of eupatilin against hydrogen peroxide-induced injury involving 5-lipoxygenase in feline esophageal epithelial cells. Korean J Physiol Pharmacol. 2012;16:313-320. https://doi.org/10.4196/kjpp.2012.16.5.313

피인용 문헌

  1. Novel Tandem Aldol Intramolecular Cyclization of SubstitutedN-Benzylpiperidine-4-one: Synthesis of Novel-Type Nitrogen 2,8-Phenanthroline Heterocycles : Novel Tandem Aldol Intramolecular Cyclization o vol.52, pp.6, 2013, https://doi.org/10.1002/jhet.2263
  2. Novel 1,8-Naphthyridine Derivatives: Design, Synthesis and in vitro screening of their cytotoxic activity against MCF7 cell line vol.17, pp.1, 2019, https://doi.org/10.1515/chem-2019-0097
  3. Novel 1,8-Naphthyridine Derivatives: Design, Synthesis and in vitro screening of their cytotoxic activity against MCF7 cell line vol.17, pp.1, 2019, https://doi.org/10.1515/chem-2019-0097
  4. A Four-Component Domino Reaction: An Eco-Compatible and Highly Efficient Construction of 1,8-Naphthyridine Derivatives, Their In Silico Molecular Docking, Drug Likeness, ADME, and Toxicity Studies vol.2021, pp.None, 2013, https://doi.org/10.1155/2021/5589837